| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/29/2001 | WO2001021780A2 Targeted gene removal |
| 03/29/2001 | WO2001021779A2 Penicillium chrysogenum transcriptional activator blar, a pathway specific regulator of beta-lactam biosynthesis, and uses therof |
| 03/29/2001 | WO2001021771A2 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 03/29/2001 | WO2001021762A2 Method of decreasing cholesterol uptake |
| 03/29/2001 | WO2001021662A1 Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium |
| 03/29/2001 | WO2001021661A1 BIVALENT INHIBITOR OF FVIIa/TF/FXa COMPLEX |
| 03/29/2001 | WO2001021660A1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm) |
| 03/29/2001 | WO2001021659A1 Novel protein component and encoding nucleic acid |
| 03/29/2001 | WO2001021658A1 32 human secreted proteins |
| 03/29/2001 | WO2001021657A1 Novel protein, gene encoding the same and method of utilization thereof |
| 03/29/2001 | WO2001021656A2 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 03/29/2001 | WO2001021655A2 Virulence gene and protein, and their use |
| 03/29/2001 | WO2001021654A2 Syk kinase-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021653A2 Ovarian tumor antigen and methods of use therefor |
| 03/29/2001 | WO2001021651A2 Novel human protease inhibitor-like proteins and polynucleotides encoding the same |
| 03/29/2001 | WO2001021649A2 Nucleic acids encoding vitamin d response element binding proteins, products related thereto, and methods of using same |
| 03/29/2001 | WO2001021648A1 Uses of kappa-conotoxin pviia |
| 03/29/2001 | WO2001021647A2 Methods of screening for compounds that modulate the lsr-leptin interaction and their use in the prevention and treatment of obesity-related diseases |
| 03/29/2001 | WO2001021646A1 Protein structures and protein fibres |
| 03/29/2001 | WO2001021645A2 Target for antiviral therapy |
| 03/29/2001 | WO2001021644A2 Wheat dp proteins and uses thereof |
| 03/29/2001 | WO2001021643A2 Parathyroid hormone analogues for the treatment of osteoporosis |
| 03/29/2001 | WO2001021641A1 Compositions and methods for the diagnosis and treatment of immune disorders |
| 03/29/2001 | WO2001021639A1 Drug target isogenes: polymorphisms in the interleukin-1 beta gene |
| 03/29/2001 | WO2001021636A1 Identification of a vaccine candidate from an extraintestinal isolate of e. coli |
| 03/29/2001 | WO2001021631A2 Secreted proteins and uses thereof |
| 03/29/2001 | WO2001021270A2 Methods for producing recombinant proteins |
| 03/29/2001 | WO2001021217A2 Method of treating cells of the prostate prophylactically or therapeutically |
| 03/29/2001 | WO2001021216A1 Capsid-modified recombinant adenovirus and methods of use |
| 03/29/2001 | WO2001021215A1 Cell based assay |
| 03/29/2001 | WO2001021204A1 Therapeutic uses of m3 polypeptide |
| 03/29/2001 | WO2001021203A1 Use of an outer membrane protein a of an enterobacterium associated with a rsv immunogenic peptide for preparing vaccines for intranasal administration |
| 03/29/2001 | WO2001021199A1 Highly efficient dendritic cell-targeted dna-vaccination |
| 03/29/2001 | WO2001021197A1 Synthesis of insulin derivatives |
| 03/29/2001 | WO2001021193A1 Hybrid peptides modulate the immune response |
| 03/29/2001 | WO2001021189A1 Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions |
| 03/29/2001 | WO2001021188A1 Utilization of fprl1 as a functional receptor by serum amyloid a (saa) |
| 03/29/2001 | WO2001021184A1 Cell-based gene therapy for the pulmonary system |
| 03/29/2001 | WO2001020989A1 Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family |
| 03/29/2001 | WO2001020977A1 Novel animal model of alzheimer disease with amyloid plaques and mitochondrial dysfunctions |
| 03/29/2001 | WO2001020973A2 Plant genes for sensitivity to ethylene and pathogens |
| 03/29/2001 | WO2001005419A3 Agent for treating cardiac diseases |
| 03/29/2001 | WO2001002557A8 Neurotrophic factor receptor |
| 03/29/2001 | WO2001000843A3 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 03/29/2001 | WO2001000673A8 Membrane-associated and secreted proteins and uses thereof |
| 03/29/2001 | WO2000077039A3 Glp-1 as a diagnostic test to determine beta-cell function |
| 03/29/2001 | WO2000077026A8 49 human secreted proteins |
| 03/29/2001 | WO2000068250A8 7tm receptor rat apj |
| 03/29/2001 | WO2000064939A3 Peptides derived from vasostatin i and the use thereof as anti-fungal agents |
| 03/29/2001 | WO2000063386A3 Prevention, diagnosis and treatment of lyme disease |
| 03/29/2001 | WO2000061742A3 Treatment of cardiac power failure using s100 proteins |
| 03/29/2001 | WO2000061067A3 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein |
| 03/29/2001 | WO2000052161A3 Leukocyte- and blood-associated proteins |
| 03/29/2001 | WO2000052148A3 Substances for controlling fertility |
| 03/29/2001 | WO2000034436A9 Facs assisted methods for introducing individual chromosomes into cells |
| 03/29/2001 | WO2000032823A9 Dna-protein fusions and uses thereof |
| 03/29/2001 | WO2000032775A9 Pth1r and pth3r receptors |
| 03/29/2001 | WO2000020607A9 Chimaeric proteins between members of tgf-beta superfamily |
| 03/29/2001 | WO1999063088A3 Membrane-bound proteins and nucleic acids encoding the same |
| 03/29/2001 | WO1999050282A3 Peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases |
| 03/29/2001 | WO1999013083A9 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth |
| 03/29/2001 | US20010000075 Neurotactin and uses therefor |
| 03/29/2001 | DE19945211A1 New autoantibody-binding peptides with an amino acid sequence corresponding a beta1-adrenergic receptor group useful for treating dilatative cardiomyopathy |
| 03/29/2001 | DE19945210A1 New autoantibody-binding peptides with an amino acid sequence corresponding a beta1-adrenergic receptor group, useful for treating dilatative cardiomyopathy |
| 03/29/2001 | DE19944870A1 Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium Signal sequences for preparing Leu-hirudin by E. coli via secretion into the culture medium |
| 03/29/2001 | CA2793128A1 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 03/29/2001 | CA2404709A1 Highly efficient dendritic cell-targeted dna-vaccination |
| 03/29/2001 | CA2388417A1 Methods of screening for compounds that modulate the lsr-leptin interaction and their use in the prevention and treatment of obesity-related diseases |
| 03/29/2001 | CA2386767A1 Novel human protease inhibitor-like proteins and polynucleotides encoding the same |
| 03/29/2001 | CA2385879A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385783A1 A pcam-1 marker protein, nucleic acid sequences encoding pcam-1 and immunoassays for detection of pcam-1 |
| 03/29/2001 | CA2385778A1 Modulation of ige receptor cell surface expression |
| 03/29/2001 | CA2385496A1 Molecules for diagnostics and therapeutics |
| 03/29/2001 | CA2385480A1 32 human secreted proteins |
| 03/29/2001 | CA2385460A1 Rgs10b, a g-protein regulator expressed in osteoclasts |
| 03/29/2001 | CA2385428A1 Novel pcna-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385404A1 Use of an outer membrane protein a of an enterobacterium associated with a rsv immunogenic peptide for preparing vaccines for intranasal administration |
| 03/29/2001 | CA2385377A1 Method to identify compounds useful in the therapy of bone disorders |
| 03/29/2001 | CA2385334A1 Novel syk kinase-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385257A1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 03/29/2001 | CA2385231A1 Nucleic acid encoding human abca transporter 2 (abca2) and methods of use thereof |
| 03/29/2001 | CA2385047A1 Uses of kappa-conotoxin pviia |
| 03/29/2001 | CA2384973A1 Seed-preferred promoter from maize |
| 03/29/2001 | CA2384932A1 Targeted gene removal |
| 03/29/2001 | CA2384928A1 Method for identifying compounds useful in the therapy of bone disorders |
| 03/29/2001 | CA2384865A1 Novel animal model of alzheimer disease with amyloid plaques and mitochondrial dysfunctions |
| 03/29/2001 | CA2384828A1 Methods for producing recombinant proteins |
| 03/29/2001 | CA2384827A1 Capsid-modified recombinant adenovirus and methods of use |
| 03/29/2001 | CA2384341A1 Parathyroid hormone analogues for the treatment of osteoporosis |
| 03/29/2001 | CA2383838A1 Method of fractional measurement of soluble cd14 protein |
| 03/29/2001 | CA2383629A1 Hybrid peptides modulate the immune response |
| 03/29/2001 | CA2383598A1 Therapeutic uses of m3 polypeptide |
| 03/29/2001 | CA2383591A1 Cell based assay |
| 03/29/2001 | CA2383276A1 Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family |
| 03/29/2001 | CA2383253A1 Conditional immortalisation of cells |
| 03/29/2001 | CA2383172A1 Utilization of fprl1 as a functional receptor by serum amyloid a (saa) |
| 03/29/2001 | CA2383093A1 Cell-based gene therapy for the pulmonary system |
| 03/29/2001 | CA2377525A1 Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions |
| 03/29/2001 | CA2319213A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof |
| 03/28/2001 | EP1087230A1 Method for identifying compounds useful in the therapy of bone disorders |